We’re always on the lookout for well-poised healthcare companies with strong fundamentals and growth prospects committed to facilitating the delivery of higher quality care at a lower cost.
Synteract is a full-service international contract research organization (CRO) with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. Synteract has conducted Phase I-IV studies on six continents and 60 countries, offering expertise across multiple therapeutic areas, with notable depth in oncology, dermatology, neuro degenerative disorders, rare and orphan diseases, and pediatrics, among other indications.
Peloton Advantage is a leading provider of medical communications services to Medical Affairs departments at pharmaceutical, biotechnology, and medical device companies. Peloton specializes in clinical-focused strategic publication planning, medical writing, health economics outcomes research and content development for medical education programs. Peloton’s teams support US and global accounts for large and small clients, contributing to the success of more than 90 products spanning all major therapeutic areas.
Children’s Choice Pediatric Dental Care is a leading dental management service organization focused exclusively on providing services to dental practices that provide pediatric dental care to a large and growing patient base across 16 locations in California. The practices affiliated with Children’s Choice provide pediatric, orthodontic, and select specialty services to children, infants, adolescents and those with special needs.
AdvancePCS was formed in October 2000 when Advance Paradigm, Inc. acquired PCS Health Systems, Inc. from Rite Aid Corporation. The combined companies created the largest pharmacy benefit manager (“PBM”) in the U.S., responsible for managing the prescription drug benefits of over 75 million people, representing over $20 billion in annual drug spending. AdvancePCS was ultimately sold to Caremark in April 2004. The company was based in Irving, Texas.
American Dental Partners is a leading provider of business services to medicallyoriented, multi-specialty dental groups in select markets in the United States. The company provides services to dentists at over 275 facilities across more than 20 states. The company is based outside of Wakefield, Massachusetts.
Medical Card Systems is among the three largest managed care organizations in Puerto Rico. The company has a significant presence in the rapidly growing Medicare Advantage market and also provides commercial health insurance through its fully insured and cost-plus business lines. The company is based in Hato Rey, Puerto Rico.
Patheon is the second largest provider of outsourced pharmaceutical development and finished dosage manufacturing services to pharmaceutical and biotechnology companies. The company has a fully integrated service offering, from analytical development and pre-formulation to commercial manufacturing (produces 750+ products for over 250 clients). The company is based in Durham, North Carolina.
PharmaNet is a leading clinical research organization (“CRO”) that provides drug development services to pharmaceutical, biotechnology, generic drug and medical device companies worldwide. PharmaNet was sold to inVentiv Health in July 2011. The company is based in Princeton, New Jersey.
SynteractHCR is a full-service international contract research organization (CRO) with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and 60 countries, offering expertise across multiple therapeutic areas, with notable depth in oncology, immunotherapy, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data to help bring tomorrow’s treatments to patients.